CJA
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Résumé de cet Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a scholarly reply
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lallo, A.
Right arrow Articles by Lacroix, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lallo, A.
Right arrow Articles by Lacroix, M.
Canadian Journal of Anesthesia 54:28-33 (2007)
© Canadian Anesthesiologists' Society, 2007

Reports of Original Investigations

Performance of the PAXpressTM vs the ProSealTM laryngeal mask airway during general anesthesia

[Efficacité du PAXpressTM et du masque laryngé ProSealTM durant l’anesthésie générale]

Alexandre Lallo, MD FRCPC, Pierre Drolet, MD FRCPC and Mélanie Lacroix, MD FRCPC

From the Department of Anesthesiology, University of Montreal, Montreal, Quebec, Canada.

Address correspondence to: Dr. Alexandre Lallo, Department of Anesthesiology, CHUM, Hôpital Notre-Dame, 1560, Sherbrooke East, Montreal, Quebec H2L 4M1, Canada. Phone: 514-890-8000, ext. 26876; Fax: 514-412-7653; E-mail: a.lallo{at}umontreal.ca

Purpose: The PAXpressTM (PAXTM) is a relatively new pharyngeal airway device that is easily inserted and effective in routine airway management. A prospective, randomized study was undertaken to compare the PAXTM with the ProSealTM laryngeal mask airway (PLMATM) during anesthesia with positive pressure ventilation.

Methods: One hundred adult patients scheduled for elective surgery under general anesthesia were randomized to airway management with either the PAXTM (n = 50) or the PLMATM (n = 50). All patients swallowed a methylene blue capsule before anesthesia. After insertion, leak and inspiratory pressures were measured. Fibrescopy was used to view the glottis. Devices were inspected for blood or methylene blue staining upon removal at the end of surgery. An interview was conducted postoperatively to evaluate the occurrence of sore throat, dysphagia and dysphonia.

Results: Insertion time was longer for the PAxTM than for the PLMATM (52 ± 44s vs 34 ± 23 sec; P = 0.003). Leak pressure was lower while peak inspiratory pressures, and EtCO2 values were higher (P = 0.016; 0.027 and 0.04 respectively) with the PAxTM. Both devices provided comparable fibreoptic viewing of the glottis. There were no differences with respect to the incidence or pattern of blue stains upon removal. Blood was seen more often on the PAxTM (58% vs 19%) and dysphagia was also more frequent and severe with the PAXTM.

Conclusion: In comparison with the PLMATM, PAXTM insertion time is longer and the ventilatory characteristics of this new device may be marginally inferior. The PAXTM is also more traumatic and is associated with more postoperative discomfort compared to the PLMATM.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by the Canadian Anesthesiologists' Society.